Market Value1,479,543,000
Total Holdings64
File Date2019-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CCXI / ChemoCentryx Inc
TSRO / TESARO, Inc.
PHAS / PhaseBio Pharmaceuticals Inc
US62857M1053 / MyoKardia, Inc.
NKTR / Nektar Therapeutics
NKTR / Nektar Therapeutics Call
DRNA / Dicerna Pharmaceuticals Inc
NERV / Minerva Neurosciences, Inc.
ZGNX / Zogenix Inc
RARX / Ra Pharmaceuticals, Inc.
CLRBW / Cellectar Biosciences, Inc. Warrants expiring 8/20/2019
GTHX / G1 Therapeutics, Inc.
ZGNX / Zogenix Inc Call
ARQL / ArQule, Inc.
QTRX / Quanterix Corporation
BOLD / Boundless Bio, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
TWST / Twist Bioscience Corporation
SGMO / Sangamo Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
MYOV / Myovant Sciences Ltd
BHVN / Biohaven Ltd.
ITRM / Iterum Therapeutics plc
CFRX / ContraFect Corp
REPL / Replimune Group, Inc.
CRSP / CRISPR Therapeutics AG
TBIO / Telesis Bio, Inc.
ALLK / Allakos Inc.
KURA / Kura Oncology, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
TBPH / Theravance Biopharma, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
INSP / Inspire Medical Systems, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
ARNA / Arena Pharmaceuticals Inc
INCY / Incyte Corporation
US74257L1089 / Principia Biopharma Inc.
TCDA / Tricida Inc
BPMC / Blueprint Medicines Corporation
KZR / Kezar Life Sciences, Inc.
DTIL / Precision BioSciences, Inc.
OTLK / Outlook Therapeutics, Inc.
IFRX / InflaRx N.V.
XLRN / Acceleron Pharma Inc
AXNX / Axonics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
RUBY / Rubius Therapeutics, Inc.
AVRO / AVROBIO, Inc.
TSRO / TESARO, Inc. Call
GNFTF / Genfit S.A.
COLL / Collegium Pharmaceutical, Inc.
ATRA / Atara Biotherapeutics, Inc.
/ Array BioPharma, Inc.
OMER / Omeros Corporation Call
MGTX / MeiraGTx Holdings plc
ACRS / Aclaris Therapeutics, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
SLDB / Solid Biosciences Inc.
YMAB / Y-mAbs Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
QTNT / Quotient Ltd
HARP / Harpoon Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
XFOR / X4 Pharmaceuticals, Inc.
HRTX / Heron Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
SAGE / Sage Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc. Put
ABEO / Abeona Therapeutics Inc.
NBIX / Neurocrine Biosciences, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
SRRK / Scholar Rock Holding Corporation
RCKT / Rocket Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
CTMX / CytomX Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.